Youtube Pro Stock Picks

Click here to search for stock quotes, financial statistics and more.

or

Analysts

KITS stock
Analysts kits
Is KITS Eyecare still a buy?

Haywood Capital Markets analyst Gianluca Tucci reiterated his “Buy” rating and $27.00 price target on KITS Eyecare (KITS Eyecare Stock Quote, Chart, News, Analysts, Financials TSX:KITS) after the company reported fourth-quarter results that were broadly in line with expectations. KITS posted Q4 revenue of $53.9-million and Adjusted EBITDA of $2.4-million, matching its preannouncement on revenue […]

DXT stock
Analysts dxt
Dexterra Group. Buy, Sell or Hold?

Beacon Securities analyst Kirk Wilson raised his price target on Dexterra Group (Dexterra Group Stock Quote, Chart, News, Analysts, Financials TSX:DXT) to $14.50 from $12.75 while maintaining a “Buy” rating following fourth-quarter results. Dexterra reported Q4 2025 revenue of $271.0-million, about 4% below Wilson’s estimate, while Adjusted EBITDA of $32.6-million was in line with forecasts. […]

WELL Health
Share Tweet linked In Share

Get Stock Picks from the Pros.
In your Inbox.

With a quarter-million users as of November 8th, more than three times the number the company expected, Transgaming's GameTreeTV is, after numerous delays, a hit.

Until now, the story of TransGaming (TSXV:TNG) has been one of incremental gains. The Toronto compan...

IMRIS CEO David Graves. On Friday, Byron Capital Healthcare Analyst Douglas Loe reiterated his BUY rating and $8 target on the stock.

On Thursday, IMRIS (TSX:IM) reported its Q4 and fiscal 2011 results. Across the board, the numbers w...

On Wednesday, Algonquin Power announced it had secured a twenty-five year Power Purchase agreement with Sask Power for a 177 megawatt wind power project, beating out twenty-seven other proposals.

On Wednesday, Algonquin Power (TSX:AQN) announced it had secured a twenty-five year Power Purchase a...

Byron Capital analyst Tom Astle says that while there are many caveats to be aware of with Bombardier and its balance sheet, there appears to be more upside than downside in its share price.

On the first day of December last year, Bombardier (TSX:BBD.B) reported its Q3, 2011 results. The Ca...

Dr. Yves Fradet, President of Diagnocure. On Wednesday, Byron Capital analyst Douglas Loe upgraded the company to Buy from Speculative Buy because he says Diagnocure is no longer as subject to clinical or regulatory risk.

This past Wednesday DiagnoCure (TSX:CUR), along with its US-based partner Gen-Probe, received FDA ap...

Dacryocytes, or teardrop-shaped cells, are found in myelofibrosis and myelophthisic states of bone marrow. Mississauga's YM Bioscience's Myelofibrosis treatment, CYT387, has performed well in Phase Two trials. Byron Capital Healthcare analyst Douglas Loe thinks this may soon attract a larger

Last Thursday, YM Biosciences (TSX:YM) reported its Q2, 2012 results. The company lost $6.55-million...

Open Text's Q2 signals the end of the John Shackleton era and the beginning of the Mark Barrenechea era. On January 2nd, the former President and CEO of Rackable took the helm at Waterloo's second most well known company.

On Wednesday, Waterloo’s Open Text (TSX:OTC) surprised the street with a particularly strong Q...

Byron Capital analyst Tom Astle says there are are similarities and important differences between Thorsten Heins at RIM and Mike Zafirovski's introduction as Nortel CEO in November of 2005.

This past Thursday, in the basement of a steakhouse in Toronto, new Research in Motion CEO Thorsten ...

Harper:

It wasn’t potash, or gold, or even lumber. Today at the World Economic Forum in Davos, Switzer...

Will the rumoured May IPO of Facebook bring even more attention to social media stocks like Calgary's Poynt? Analyst Byron Berry says he is struck by the similarities between Poynt and San Francisco based IPO candidate Yelp.

In the public markets, the social media frenzy that will no doubt reach its pinnacle with the IPO of...

Last Friday, in a U.S. district court in Florida, Ottawa's Wi-LAN launched a patent suit against Research in Motion.

On Friday, about forty-eight hours before the surprising news broke that Thorsten Heins was named ne...

Could Mark Barrenechea, who became CEO of Waterloo's Open Text on January 2nd, be fielding offers for the company in 2012?

In 2011, the story of the year in Canadian tech was buyouts. Many of our most interesting Canadian c...

In order for any company to weather the many storms it is likely to encounter as it progresses from ...

Neptune Technologies

Neptune Technologies (TSXV:NTB) yesterday reported its Q3, 2012 results. The numbers appeared to be ...

Waddell:

In Canada, the shadow of Nortel is large and, seemingly, persistent. The fallen Ottawa tech giant, w...

Descartes Systems Group CEO Art Mesher. Versant Partners analyst Tom Liston has a $10 target on Descartes.

UPDATE! We’ve updated the analyst picks for 2013, check out the Top Picks of some of Canada...

The management team of Waterloo's Sandvine. Fiscal 2011 was a step backward for the company, which had been steadily improving for a number of years.

On Thursday, Sandvine (TSX:SVC) announced its fiscal 2011 results. Revenue came in at (US) $89.3 mil...

WELL Health
Share Tweet linked In Share

Get Stock Picks from the Pros. In your Inbox.

TRENDING

All Trending →
GTII stock

This cannabis stock is a “Top Pick” for 2026, analyst says

 March 2, 2026
TRUL Stock

Is Trulieve Cannabis a buy right now?

 March 2, 2026
MDA stock

Space is not the Final Frontier for MDA, this analyst says

 February 23, 2026
T stock

Why a banker makes sense as Telus’s new boss

 February 19, 2026
WEED stock

Here’s the problem with Canopy Growth stock

 February 13, 2026